Comparable to medical targeted therapy, PSMA radio-guided surgery facilitates targeted molecular surgery, as it allows for the specific intraoperative detection of PSMA-expressing prostate-cancer deposits, especially for the intraoperative detection of atypically positioned lesions and small subcentimeter metastatic lymph nodes [41,42]. This evidence concerns the gene FOLH1 and prostate carcinoma.